BRVE
Braveheart Bio, Inc.CIK 0002131524 · SIC 2834 · Pharmaceutical Preparations
No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (NTSK 10-Q) is open in full — no account needed.
Summary not yet generated.
Braveheart Bio prices $382.5M IPO at $18/share; net proceeds $351.2M fund BHB-1893 Phase 3 trials
6 material changes detected. Sign up free to read the summary.
Partner
Trade BRVE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Braveheart Bio sets $16 IPO terms, $274.5M net proceeds, and 2029 cash runway
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.